FDA Inspection 1225550 — Bioreliance Ltd.
The FDA completed an inspection of Bioreliance Ltd. on Nov 7, 2023 in Glasgow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Glasgow (United Kingdom)